Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles. - Wikidata - awgldk - TriplyDB

Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles.

Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles.

http://www.wikidata.org/entity/Q40005854

about

Dinosaurs and ancient civilizations: reflections on the treatment of cancer Polo-like kinase and its inhibitors: Ready for the match to start?Neoplasia: the second decade.Cytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristics Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients.The War on Cancer rages on.Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck.ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.Albumin nanoshell encapsulation of near-infrared-excitable rare-Earth nanoparticles enhances biocompatibility and enables targeted cell imaging.Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer.Uptake of plasmid-loaded nanoparticles in breast cancer cells and effect on Plk1 expression.Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel.Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer.Targeting the cell cycle in esophageal adenocarcinoma: an adjunct to anticancer treatment The balance of Polo-like kinase 1 in tumorigenesis.Recent progress in oligonucleotide therapeutics: antisense to aptamers.

P2860

Q24628746-4C8BBBF6-F7B5-4389-8A64-896C4351DE7E Q28087433-A5D1BE6A-5D2C-4351-87FA-9B70A21965BC Q30484000-79294302-C35B-4AEF-8BF0-0F43D8721703 Q34251855-7F4B65B9-B1D8-423B-8E52-B0F94870BE3D Q35654260-48EB48BD-4859-4122-A0A1-54019018858A Q37335160-3F9BFEDF-821D-41C0-9361-E72235222E67 Q37478602-67D41C80-049F-47C3-966D-9DE14A7578D5 Q37776652-F3452EF4-FBF6-4694-AFCE-E4991309B752 Q38292744-1FCA8A8E-D23D-4B2E-8FC7-BC5D919A485B Q38982783-6B29CDE0-661F-47B3-8647-D945525FB033 Q39361870-B26F21D4-2D62-4E78-880D-8402F96F1535 Q39687300-E4A037D6-9D6C-4E85-8169-10426B56E6F4 Q39687832-FD8CF5B5-D0FA-4747-8D50-4CE1C29B74DD Q39826698-46CD3D7F-BA5D-47AE-A78D-FA28A9D4731E Q39841379-E35D8377-B9EE-488A-85D8-7739167D1471 Q42088063-2BCA7096-995D-4485-9EBE-95802FC6BA1A Q42723757-32BEE2BB-02F4-4536-9E4E-944B9E82E399 Q43180721-1E705A3D-2732-4097-9749-AD5BE1CF72F7 Q47563314-872CDBF6-AC88-4899-B8A4-75849A1BE5AE

P2860

Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles.

http://www.wikidata.org/entity/Q40005854

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Downregulation of Plk1 express ...... cleotide-loaded nanoparticles.

@en

type

label

Downregulation of Plk1 express ...... cleotide-loaded nanoparticles.

@en

prefLabel

Downregulation of Plk1 express ...... cleotide-loaded nanoparticles.

@en

P1433

Q40005854-C7B68993-3E7B-437A-9D45-EAA843AFA95A

P1476

Q40005854-E8324429-90C7-4E23-9B3D-49347CBD667C

P2093

Q40005854-01E3487E-061C-406B-958E-38AB4CB98001

Q40005854-487B4B3C-FDB9-490B-BA55-A3B228FC7945

Q40005854-54B8F950-34F2-496F-AF45-152ACE0A0FD4

Q40005854-57656424-7A9C-46BE-8DEA-CB82C21B10B4

Q40005854-AF95F4CA-458C-4CCB-ADD9-084A2F50BCB2

Q40005854-BC11AAD9-8B36-4830-A885-79EA1ACB178A

P2860

Q40005854-00E2934E-2F71-49A0-8A1E-8FAF4685D346

Q40005854-02F03E82-134B-4006-9714-3F7FC96EA5CC

Q40005854-12B039B5-06A7-4B12-B829-4253ECEC19CF

Q40005854-179746FA-65E6-43E9-8B5C-91C0302AA223

Q40005854-19671D3B-F96F-4DCB-88A2-8A91CC866A05

Q40005854-1DD9E1A0-67F0-4F43-BE3E-F306690A35E1

Q40005854-20E7D89F-100E-489C-9CB1-B2CF0C81ABA3

Q40005854-22BA85EB-FB9C-441B-9ADA-05137C757076

Q40005854-35806709-8B92-498E-B212-DA12FA96CA0D

Q40005854-3890AA24-8584-4E30-86BF-5063BBFEE147

P304

Q40005854-B62A8F3A-D72B-44D8-A3FB-316C6DC5763C

P31

Q40005854-7503C22B-1B2F-4679-95AC-7672B4DD5434

P356

Q40005854-EF5FD7CC-B262-4827-BBAA-C242719390CC

P433

Q40005854-F3347010-3750-43BC-94EC-F99360C4796D

P478

Q40005854-EE9A55AD-1874-4774-8A7D-A598952D30D6

P577

Q40005854-C4F88AFC-8DB9-462C-9F8B-77E13FF1F4E7

P5875

Q40005854-4148B81B-3CFF-406D-975B-AD06ECEDEC2C

P698

Q40005854-6E8CE0E2-7461-4425-8292-6C343A9FE014

P921

Q40005854-BA2624BF-1C77-49BB-A8BF-52EAA222AA28

P932

Q40005854-B436C6E1-42F5-4F27-8281-DD82B5DBC080

P356

P1433

P1476

Downregulation of Plk1 express ...... cleotide-loaded nanoparticles.

@en

P2093

Birgit Spänkuch

http://www.w3.org/2001/XMLSchema#string

Elisabeth Kurunci-Csacsko

http://www.w3.org/2001/XMLSchema#string

Heidrun Wartlick

http://www.w3.org/2001/XMLSchema#string

Isabel Steinhauser

http://www.w3.org/2001/XMLSchema#string

Klaus I Strebhardt

http://www.w3.org/2001/XMLSchema#string

Klaus Langer

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors

Cancer statistics, 2006

Polo-like kinases and the orchestration of cell division

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells.

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

P304

223-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.07916

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5532349

http://www.w3.org/2001/XMLSchema#string

P698

18320067

http://www.w3.org/2001/XMLSchema#string

P921

P932

2259452

http://www.w3.org/2001/XMLSchema#string